Efficacy News and Research

RSS
Immunomedics awarded U.S. and Australian patents

Immunomedics awarded U.S. and Australian patents

Promising new tuberculosis drug enters clinical trial

Promising new tuberculosis drug enters clinical trial

Study examines biomarkers for response to erlotinib in glioma

Study examines biomarkers for response to erlotinib in glioma

The most frequently used drugs for treating chronic insomnia have never been approved for that purpose

The most frequently used drugs for treating chronic insomnia have never been approved for that purpose

Invasive treatment including stenting may be more effective for heart attack patients who arrive late at hospital

Invasive treatment including stenting may be more effective for heart attack patients who arrive late at hospital

Rimonabant study shows significant improvements in HbA1c and cardiometabolic risk factors in people with type 2 diabetes

Rimonabant study shows significant improvements in HbA1c and cardiometabolic risk factors in people with type 2 diabetes

European approval of Temodal (temozolomide) capsules for treatment of glioblastoma multiforme

European approval of Temodal (temozolomide) capsules for treatment of glioblastoma multiforme

Digital mammography no better than traditional film X-rays in the ability to detect cases of breast cancer

Digital mammography no better than traditional film X-rays in the ability to detect cases of breast cancer

Similarities in antiretroviral therapy efficacy in poorer countries to that in industrial nations

Similarities in antiretroviral therapy efficacy in poorer countries to that in industrial nations

Lorus Therapeutics receives patent allowance to protect novel anticancer drug

Lorus Therapeutics receives patent allowance to protect novel anticancer drug

MabThera highly effective in treating rheumatoid arthritis

MabThera highly effective in treating rheumatoid arthritis

Rituximab, used to treat rheumatoid arthritis (RA) is safe and effective

Rituximab, used to treat rheumatoid arthritis (RA) is safe and effective

Virulizin granted orphan drug status in Europe

Virulizin granted orphan drug status in Europe

IGF-based growth hormone dosing could become a novel paradigm in treating growth hormone deficiency

IGF-based growth hormone dosing could become a novel paradigm in treating growth hormone deficiency

Doctors study surgery to stop epileptic seizures

Doctors study surgery to stop epileptic seizures

World first air purification technology for H5N1 Avian Influenza

World first air purification technology for H5N1 Avian Influenza

Helmholtz Institute develops a new path to more effective antibiotics

Helmholtz Institute develops a new path to more effective antibiotics

One-a-day tablet treats common infection

One-a-day tablet treats common infection

Chemotherapy options improve for patients with advanced colorectal cancer

Chemotherapy options improve for patients with advanced colorectal cancer

One-time whooping cough vaccination at 11 years of age may potentially be cost-effective

One-time whooping cough vaccination at 11 years of age may potentially be cost-effective

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.